LENZ
Price:
$6.77
Market Cap:
$212.27M
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.
Industry
Biotechnology
IPO Date
2024-03-22
Stock Exchange
NASDAQ
Ticker
LENZ
According to LENZ Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 187.73M. This represents a change of -73.42% compared to the average of 706.39M of the last 4 quarters.
The mean historical Enterprise Value of LENZ Therapeutics, Inc. over the last ten years is 440.22M. The current 187.73M Enterprise Value has changed 4.16% with respect to the historical average. Over the past ten years (40 quarters), LENZ's Enterprise Value was at its highest in in the September 2025 quarter at 1.30B. The Enterprise Value was at its lowest in in the March 2024 quarter at -100650950.87.
Average
440.22M
Median
469.23M
Minimum
66.19M
Maximum
728.68M
Discovering the peaks and valleys of LENZ Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 799.88%
Maximum Annual Enterprise Value = 728.68M
Minimum Annual Increase = -83.17%
Minimum Annual Enterprise Value = 66.19M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 436.18M | -26.77% |
| 2024 | 595.61M | 799.88% |
| 2023 | 66.19M | -16.18% |
| 2022 | 78.96M | -83.17% |
| 2021 | 469.23M | -33.60% |
| 2020 | 706.67M | -3.02% |
The current Enterprise Value of LENZ Therapeutics, Inc. (LENZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
365.99M
5-year avg
329.23M
10-year avg
440.22M
LENZ Therapeutics, Inc.’s Enterprise Value is less than GH Research PLC (1.21B), less than ARS Pharmaceuticals, Inc. (1.04B), less than Nanobiotix S.A. (1.60B), less than Maravai LifeSciences Holdings, Inc. (2.49B), less than Rezolute, Inc. (375.04M), less than Geron Corporation (918.81M), less than Tyra Biosciences, Inc. (1.53B), less than Savara Inc. (1.07B), less than Prime Medicine, Inc. (551.62M), less than Arbutus Biopharma Corporation (818.44M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.21B | $1.45B | |
| 1.04B | $969.20M | |
| 1.60B | $1.80B | |
| 2.49B | $1.38B | |
| 375.04M | $385.17M | |
| 918.81M | $737.75M | |
| 1.53B | $1.61B | |
| 1.07B | $1.08B | |
| 551.62M | $501.21M | |
| 818.44M | $841.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LENZ Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LENZ Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is LENZ Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for LENZ Therapeutics, Inc. (LENZ)?
What is the 3-year average Enterprise Value for LENZ Therapeutics, Inc. (LENZ)?
What is the 5-year average Enterprise Value for LENZ Therapeutics, Inc. (LENZ)?
How does the current Enterprise Value for LENZ Therapeutics, Inc. (LENZ) compare to its historical average?